Product Description
Size: 100µL
Rabbit Polyclonal LCLAT1 antibody. Suitable for IHC-P, ICC and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human LCLAT1 aa 200-350.
Key facts
Host species:Rabbit,
Clonality:Polyclonal,
Isotype:IgG,
Carrier free:No,
Reacts with:Human,
Applications:IHC-P, ICCSee reactivity dataSee the reactivity data table below for information on validated species and application combinations.,
Immunogen:Recombinant Fragment Protein within Human LCLAT1 aa 200-350. The exact immunogen used to generate this antibody is proprietary information.Q6UWP7
Properties and Storage Information:
Form-Liquid, Purification technique-Affinity purification Immunogen, Storage buffer-pH: 7.2Preservative: 0.02% Sodium azideConstituents: PBS, 40% Glycerol (glycerin, glycerine), Shipped at conditions-Blue Ice, Appropriate short-term storage conditions-+4°C, Appropriate long-term storage conditions--20°C, Aliquoting information-Upon delivery aliquot, Storage information-Avoid freeze / thaw cycle
Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
Lysocardiolipin acyltransferase 1 (LCLAT1) also known as monolysocardiolipin acyltransferase (MLCL AT-1) is an enzyme with a mass of approximately 58 kDa. LCLAT1 resides primarily in the mitochondria and plays a significant role in phospholipid metabolism by catalyzing the reacylation of monolysocardiolipin (MLCL) to cardiolipin (CL). This function is critical for maintaining mitochondrial membrane structure and function. Expression of LCLAT1 occurs in various tissues with notable presence in heart and skeletal muscle where high energy demand correlates with mitochondrial activity.
Biological function summary
LCLAT1 functions within the lipid remodeling pathway specific to the mitochondria and is an important player in the maintenance of mitochondrial function and energy metabolism. This enzyme acts independently not as part of a larger protein complex. LCLAT1 ensures the proper composition of cardiolipin which is essential for the optimal performance of respiratory chain complexes and cellular energy homeostasis.
Pathways
The enzyme LCLAT1 plays a vital role in lipid metabolism particularly the remodeling pathway of cardiolipin in mitochondria. This pathway is vital for the functionality of the electron transport chain an important element in cellular respiration. LCLAT1 interconnects with Tafazzin (TAZ) another enzyme critical in cardiolipin biosynthesis and remodeling highlighting its participation in maintaining mitochondrial health and efficient aerobic energy supply.
Alterations in LCLAT1 function have connections to mitochondrial diseases due to its role in cardiolipin remodeling. Disruptions in its activity may relate to Barth syndrome a genetic disorder linked to defects in cardiolipin metabolism. LCLAT1's association with Tafazzin (TAZ) further implicates it in the disorder as both proteins are essential for proper cardiolipin function and mitochondrial integrity.
Order Guidelines
1. Price & Stock Available on Request. Click to send email to: service@iright.com
2. Please DO NOT make payment before confirmation.
3. Minimum order value of $1,000 USD required.
Collaboration
Tony Tang
Email: Tony.Tang@iright.com
Mobile/WhatsApp/Wechat: +86-17717886924